Global Animal Drug Compounding Market Size and Forecast 2024-2033|Wedgewood Pharmacy LLC, Triangle Compounding Pharmacy Inc., Davis Islands Pharmacy & Compounding Lab, Custom Med Compounding Pharmacy, Central Compounding Center South LLC

The Animal Drug Compounding by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Animal Drug Compounding Market:

https://www.thebusinessresearchcompany.com/report/animal-drug-compounding-global-market-report

According to The Business Research Company’s Animal Drug Compounding, The animal drug compounding market size has grown strongly in recent years. It will grow from $1.56 billion in 2023 to $1.69 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to regulatory landscape, veterinary practices, market awareness, limited commercial options, veterinary collaboration.

The animal drug compounding market size is expected to see strong growth in the next few years. It will grow to $2.23 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to regulatory developments, pet ownership trends, specialized veterinary care, globalization of veterinary services, advancements in veterinary medicine.. Major trends in the forecast period include focus on flavoring and palatability, demand for specialized dosage forms, collaboration between veterinarians and compounding pharmacists, focus on pain management solutions, growing role in veterinary hospice care.

A rise in the rate of animal adoption is expected to propel the growth of the animal drug compounding market going forward. Animal adoption is defined as acquiring animals through rescue groups instead of purchasing them from pet shops or breeders. Adopted animals may have pre-existing health conditions or may require medications that are not available in standard formulations, which create a demand for customized animal medications. As more pet owners may seek customized medications for their adopted animals, the need for animal drug compounding increases. For instance, in 2021, according to Chewy, Inc., a US-based online retailer of pet food and other products, there were around 977,202 pets adopted in the US in 2021, which resulted in the highest adoption rate of 61% in the past six years. Moreover, in November 2022, according to a national survey of pets and people published by Animal Medicines Australia (AMA), an Australia-based industry body representing the leaders of the animal health industry in Australia, in 2022, 48% of Australian households had dogs, up from 40% in 2019. Therefore, the rise in the rate of animal adoption is driving the growth of the animal drug compounding market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=9964&type=smp

The animal drug compounding market covered in this report is segmented –

1) By Animal Type: Companion Animals, Livestock Animals

2) By Product: Anti-infective Agents, Anti-inflammatory Agents, Hormones And Substitutes, CNS Agents, Other Products

3) By Route of Administration: Oral, Injectable, Topical, Other Routes Of Administration

4) By Application: Veterinary Hospitals, Veterinary Clinics, Veterinary Diagnostic Centers

Major companies operating in the animal drug compounding market are investing in animal drug compounding technologies to drive revenues in the market. The organ-on-a-chip technology developed by Revivo BioSystems simulates the interaction of human skin with the substance being tested, providing a quicker, more reliable, and cost-efficient alternative to animal testing. For instance, in December 2021, Evonik, a Germany-based specialty chemicals company, made a significant investment in Revivo BioSystems, a Singapore-based startup that has developed a technology using a realistic 4D model of human skin for the testing of chemical, cosmetic, and pharmaceutical compounds. This investment is part of Evonik’s commitment to supporting emerging technologies that offer alternatives to traditional research methods and accelerate more sustainable and ethical practices.

The animal drug compounding market report table of contents includes:

1. Executive Summary

2. Animal Drug Compounding Market Characteristics

3. Animal Drug Compounding Market Trends And Strategies

4. Animal Drug Compounding Market – Macro Economic Scenario

5. Global Animal Drug Compounding Market Size and Growth

26. South America Animal Drug Compounding Market

27. Brazil Animal Drug Compounding Market

28. Middle East Animal Drug Compounding Market

29. Africa Animal Drug Compounding Market

30. Animal Drug Compounding Market Competitive Landscape And Company Profiles

Top Major Players: